Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M189,718Revenue $M51,584Net Margin (%)20.7Z-Score2.6
Enterprise Value $M193,846EPS $3.2Operating Margin %26.8F-Score6
P/E(ttm))18.8Cash Flow Per Share $3.5Pre-tax Margin (%)26.8Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %3.2Quick Ratio2.4Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %8.5Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %2.3ROA % (ttm)6.0Higher Current Ratio y-yY
Dividend Yield %3.4Insider Buy (3m)0ROE % (ttm)13.4Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M6,379ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 29.8-1%Add 105.23%14,934,022
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 29.8-1%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 29.8-1%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06%$29.02 - $32.4
($30.05)
$ 29.8-1%Add 250.56%393,008
PFEMichael Price 2014-06-30 Reduce-0.97%$29.02 - $32.4
($30.05)
$ 29.8-1%Reduce -69.14%107,100
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 29.8-1%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 29.8-1%Reduce -70.71%2,303,762
PFEJohn Hussman 2014-06-30 Sold Out -0.04%$29.02 - $32.4
($30.05)
$ 29.8-1%Sold Out0
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 29.8-5%Add 356.54%1,014,808
PFEJohn Hussman 2014-03-31 Buy 0.04%$29.66 - $32.75
($31.36)
$ 29.8-5%New holding, 17000 sh.17,000
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 29.8-5%Reduce -40.13%7,276,622
PFEJean-Marie Eveillard 2014-03-31 Reduce-0.19%$29.66 - $32.75
($31.39)
$ 29.8-5%Reduce -22.77%7,866,473
PFEJean-Marie Eveillard 2013-12-31 Add0.16%$28.24 - $32.2
($30.7)
$ 29.8-3%Add 23.07%10,186,005
PFEJoel Greenblatt 2013-12-31 Add0.11%$28.24 - $32.2
($30.7)
$ 29.8-3%Add 241.71%222,280
PFERonald Muhlenkamp 2013-12-31 Add0.05%$28.24 - $32.2
($30.7)
$ 29.8-3%Add 29.15%45,129
PFERay Dalio 2013-12-31 Add0.01%$28.24 - $32.2
($30.7)
$ 29.8-3%Add 102.18%110,408
PFEVanguard Health Care Fund 2013-12-31 Reduce-0.91%$28.24 - $32.2
($30.7)
$ 29.8-3%Reduce -43.19%12,153,122
PFECharles Brandes 2013-12-31 Reduce-0.22%$28.24 - $32.2
($30.7)
$ 29.8-3%Reduce -9.32%5,767,402
PFEDavid Dreman 2013-12-31 Reduce-0.15%$28.24 - $32.2
($30.7)
$ 29.8-3%Reduce -85.73%10,163
PFEDonald Yacktman 2013-12-31 Sold Out -0.01%$28.24 - $32.2
($30.7)
$ 29.8-3%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE Ray Dalio 2014-06-30393,0080.010.09+250.56%
PFE Vanguard Health Care Fund 2014-06-3014,934,0220.231.2+105.23%
PFE Joel Greenblatt 2014-06-301,741,3140.030.65+71.59%
PFE David Dreman 2014-06-3013,61500.03+14.88%
PFE Charles Brandes 2014-06-306,075,4600.12.2+5.78%
PFE James Barrow 2014-06-3060,500,0580.952.4+1.01%
PFE Prem Watsa 2014-06-30235,00000.48
PFE Ruane Cunniff 2014-06-3010,98700-0.32%
PFE Ronald Muhlenkamp 2014-06-3041,01900.21-0.36%
PFE Mario Gabelli 2014-06-301,104,0700.020.17-5.28%
PFE John Keeley 2014-06-3089,83900.05-6.31%
PFE Dodge & Cox 2014-06-3048,902,0970.771.4-23.73%
PFE Michael Price 2014-06-30107,10000.39-69.14%
PFE Jean-Marie Eveillard 2014-06-302,303,7620.040.17-70.71%
PFE John Hussman 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.530.34view
Germano Geno JGroup President 2014-06-02Sell30,000$29.68-0.17view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.38-5.58view
PFIZER INC10% Owner 2014-03-12Buy272,727$11169.36view
CANGIALOSI LORETTA VSr. Vice President, Controller 2014-03-04Sell102,943$32.05-7.55view
Dolsten MikaelPresident R&D 2014-03-04Sell35,789$32.58-9.05view
SUSMAN SALLYExecutive Vice President 2014-03-04Sell67,585$32.59-9.08view
PFIZER INC10% Owner 2014-02-04Buy227,261$8270.38view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell131,810$30.82-3.86view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell28,190$30.86-3.99view

Press Releases about PFE :

    Quarterly/Annual Reports about PFE:

      News about PFE:

      Articles On GuruFocus.com
      A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
      The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 
      The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 
      I Am Sure This Pharma-Company Suits Your Portfolio Aug 28 2014 
      Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
      Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG Aug 18 2014 
      A Strong Candidate for Investor´s Portfolios Aug 12 2014 
      Legendary Investor Irving Kahn's Top Five Stocks Aug 08 2014 
      Widely Held Guru Stocks Near 52-Week Lows Aug 05 2014 
      Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS Aug 04 2014 


      More From Other Websites
      Why multinationals aren't adding U.S. jobs Sep 28 2014
      Pfizer drug effective in patients with rare lung cancer -study Sep 27 2014
      Pfizer’s Lung Cancer Drug Helps Patients With Gene Defect Sep 27 2014
      [video] Stock Pops & Drops: AGIO, MO, PFE & MU Sep 26 2014
      Pfizer Acquires InnoPharma, Injectables Business to Benefit Sep 26 2014
      Focusing Solely On Animal Health Sets Zoetis Apart Sep 26 2014
      GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel Sep 26 2014
      Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch Sep 26 2014
      [video] Fast Money Final Trade: PFE, DOW, VRTX & the dollar Sep 25 2014
      Fast Money Final Trade: PFE, DOW, VRTX & the dollar Sep 25 2014
      Pfizer Completes Acquisition Of InnoPharma Sep 25 2014
      New FDA label bolsters safety case for Chantix Sep 24 2014
      [video] The Top Ten Stocks for Sept. 24 Sep 24 2014
      Taking Stock: Sherman, Eisenberg Discuss Tax Inversion Sep 24 2014
      Smoke This: Pfizer Wants Serious Warnings Removed From Chantix Sep 24 2014
      [$$] Pfizer Held Takeover Talks With Actavis Sep 24 2014
      New FDA label bolsters safety case for Chantix Sep 24 2014
      [video] The Top Ten Stocks for Wednesday, September 24 Sep 24 2014
      Faber: Actavis pursues Salix Sep 24 2014
      AstraZeneca suitor Pfizer eyes another target Sep 24 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      SEENSCO
      ReplySEENSCO - 3 months ago
      PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK